TOPLINE: Fatigue, a common symptom immediately after a transient ischemic attack (TIA), persists up to a year after the event in 53.8% of patients, a new […]
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the first blood test to aid in diagnosing Alzheimer’s disease (AD). The Lumipulse G […]
TOPLINE: Use of nucleoside reverse transcriptase inhibitors (NRTIs), but not other medications for HIV, was associated with a significantly reduced risk for Alzheimer’s disease (AD) in […]
An investigational oral selective orexin receptor 2 agonist (oveporexton, Takeda) demonstrated significantly improved measures of wakefulness, sleepiness, and cataplexy in a phase 2b study of adults […]
The largest study to date of magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor identified a target area within the ventral intermediate nucleus (VIM) that could […]
We’ve long known that migraine is an insidious disease. Patients with a variety of existing illnesses — atopic disorders, cardiovascular diseases, and sleep and/or psychiatric disorders […]
(Reuters) -The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals’ self-administered migraine drug, giving way to a quick and more convenient treatment option for patients. […]
What has been described as a mysterious neurologic syndrome of unknown cause (NSUC) in the Canadian province of New Brunswick is a “perfect storm” of “misdiagnosis, […]
TOPLINE: A secondary analysis of the MR CLEAN-LATE trial found that penumbra volumes significantly modified the effectiveness of endovascular treatment (EVT) in patients with stroke in […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.